Helius Medical Technologies Inc (HSDT)
1.51
-0.01
(-0.66%)
USD |
NASDAQ |
May 17, 16:00
1.51
0.00 (0.00%)
After-Hours: 18:58
Helius Medical Technologies Cash from Operations (Quarterly): -2.034M for Dec. 31, 2023
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -2.034M |
| September 30, 2023 | -2.452M |
| June 30, 2023 | -2.74M |
| March 31, 2023 | -3.19M |
| December 31, 2022 | -2.143M |
| September 30, 2022 | -3.821M |
| June 30, 2022 | -3.664M |
| March 31, 2022 | -4.682M |
| December 31, 2021 | -3.463M |
| September 30, 2021 | -3.235M |
| June 30, 2021 | -3.769M |
| March 31, 2021 | -2.921M |
| December 31, 2020 | -2.171M |
| September 30, 2020 | -2.588M |
| June 30, 2020 | -3.228M |
| March 31, 2020 | -3.751M |
| December 31, 2019 | -4.539M |
| September 30, 2019 | -5.246M |
| June 30, 2019 | -4.414M |
| March 31, 2019 | -6.80M |
| December 31, 2018 | -5.145M |
| Date | Value |
|---|---|
| September 30, 2018 | -3.348M |
| June 30, 2018 | -6.268M |
| March 31, 2018 | -4.86M |
| December 31, 2017 | -5.086M |
| September 30, 2017 | -4.943M |
| June 30, 2017 | -6.432M |
| March 31, 2017 | -2.864M |
| September 30, 2016 | -1.724M |
| June 30, 2016 | -2.369M |
| March 31, 2016 | -1.683M |
| December 31, 2015 | -2.861M |
| September 30, 2015 | -1.248M |
| June 30, 2015 | -2.146M |
| March 31, 2015 | -1.941M |
| December 31, 2014 | -1.621M |
| September 30, 2014 | -2.218M |
| June 30, 2014 | -0.5409M |
| March 31, 2014 | -0.3217M |
| December 31, 2013 | -0.0099M |
| September 30, 2013 | -0.017M |
| June 30, 2013 | 0.00 |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-5.246M
Minimum
Sep 2019
-2.034M
Maximum
Dec 2023
-3.371M
Average
-3.235M
Median
Sep 2021
Cash from Operations (Quarterly) Benchmarks
| ARCA biopharma Inc | -1.528M |
| Integra Lifesciences Holdings Corp | 15.76M |
| NeuroOne Medical Technologies Corp | -3.809M |
| Perspective Therapeutics Inc | -9.008M |
| Electromed Inc | 1.351M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -0.003M |
| Cash from Financing (Quarterly) | 0.622M |
| Free Cash Flow | -10.44M |
| Free Cash Flow Per Share (Quarterly) | -2.870 |
| Free Cash Flow to Equity (Quarterly) | -2.037M |
| Free Cash Flow to Firm (Quarterly) | -2.037M |
| Free Cash Flow Yield | -1.10K% |